Downregulation of HBx mRNA in HepG2.2.15 cells by small interfering RNA

被引:6
作者
Jiao, Jing [1 ]
Cao, Hong [2 ]
Chen, Xiao-Wei [1 ]
Zhou, Mei-juan [1 ]
Liu, Zhi-hua [3 ]
Ding, Zhen-hua [1 ]
机构
[1] So Med Univ, Sch Publ Hlth & Trop Med, Dept Radiat Med, Guangzhou 510515, Guangdong, Peoples R China
[2] So Med Univ, Dept Microbiol, Guangzhou 510515, Guangdong, Peoples R China
[3] Nanfang Hosp, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China
关键词
hepatitis B virus x protein; HepG2.2.15; cells; real-time reverse-transcript PCR; RNA interference; small interfering RNA; western blot;
D O I
10.1097/MEG.0b013e3282748ee2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective Hepatitis B virus (HBV) infection is one of the most prevalent viral infectious diseases in humans. And it is still a challenge for the development of an effective therapy for HBV infection. Recently, the progress in RNA interference (RNAi) has shed some light on the inhibition of HBV expression and replication by RNAi specific for the various genes of the HBV genome. Some prior researches suggests that the HBV x protein (HBx) plays an important role in viral transcription, cell growth, and apoptotic cell death. Methods In the present study, we designed three siRNAs based on the X-protein of HBV sequences and tested their effects on the expression of HBx gene following sorting of siRNA-positive cells. The interference effect was tested in 24, 48, and 72 h. HBsAg in cultured media was assayed using western blot at various days post-transfection. The amount of HBx mRNA was quantitated by Real-time reverse-transcript PCR (RT-PCR). Results There was a decrease in the levels of HBV mRNA and HBsAg from the the transfected cells. Among these three siRNAs, siRNA-2 was found to be the most effective at suppressing HBV gene expression.
引用
收藏
页码:1114 / 1118
页数:5
相关论文
共 32 条
[21]   Hepatitis B virus biology [J].
Seeger, C ;
Mason, WS .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2000, 64 (01) :51-+
[22]   Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx [J].
Sirma, H ;
Giannini, C ;
Poussin, K ;
Paterlini, P ;
Kremsdorf, D ;
Bréchot, C .
ONCOGENE, 1999, 18 (34) :4848-4859
[23]   Novel ring-expanded nucleoside analogs exhibit potent and selective inhibition of hepatitis B virus replication in cultured human hepatoblastoma cells [J].
Sood, RK ;
Bhadti, VS ;
Fattom, AI ;
Naso, RB ;
Korba, BE ;
Kern, ER ;
Chen, HM ;
Hosmane, RS .
ANTIVIRAL RESEARCH, 2002, 53 (02) :159-164
[24]   Intracellular inhibition of hepatitis B virus S gene expression by chimeric DNA-RNA phosphorothioate minimized ribozyme [J].
Tan, TMC ;
Zhou, L ;
Houssais, S ;
Seet, BL ;
Jaenicke, S ;
Peter, F ;
Lim, SG .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2002, 12 (04) :257-264
[25]   p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro [J].
Terradillos, O ;
Pollicino, T ;
Lecoeur, H ;
Tripodi, M ;
Gougeon, ML ;
Tiollais, P ;
Buendia, MA .
ONCOGENE, 1998, 17 (16) :2115-2123
[26]   Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNA [J].
Uprichard, SL ;
Boyd, B ;
Althage, A ;
Chisari, FV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) :773-778
[27]   Is combination therapy with lamivudine and interferon-alpha superior to monotherapy with either drug? [J].
van Nunen, AB ;
Janssen, HLA ;
Wolters, LMM ;
Niesters, HGM ;
de Man, RA ;
Schalm, SW .
ANTIVIRAL RESEARCH, 2001, 52 (02) :139-146
[28]   RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant [J].
Wu, HL ;
Huang, LR ;
Huang, CC ;
Lai, HL ;
Liu, CJ ;
Huang, YT ;
Hsu, YW ;
Lu, CY ;
Chen, DS ;
Chen, PJ .
GASTROENTEROLOGY, 2005, 128 (03) :708-716
[29]  
Ying C, 2000, J VIRAL HEPATITIS, V7, P79
[30]   Selective inhibition of hepatitis B virus replication by RNA interference [J].
Ying, CX ;
De Clercq, E ;
Neyts, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 309 (02) :482-484